Arvinas Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include Lyell.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations South San Francisco, US HQ Bothell, US Seattle, US |
Employees | Employees 16135% increase | Employees 188 |
Valuation ($) | Valuation ($) 458.1 m | Valuation ($) 353.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $34.2m (FY, 2023) | Revenue (est.) $130k (FY, 2023) |
Net income | Net income ($98.4m) (FY, 2023) | Net income ($234.6m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company